S-calprotectin (S100A8/S100A9): a potential marker of inflammation in patients with psoriatic arthritis.

S-calprotectin (S100A8/S100A9): a potential marker of inflammation in patients with psoriatic arthritis.

Item
http://www.wikidata.org/entity/Q33739148
Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.Interleukin 6 regulates psoriasiform inflammation-associated thrombosis.Biomarkers in psoriatic arthritis: a systematic literature review.Macrophage-mediated psoriasis can be suppressed by regulatory T lymphocytes.Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases.Insights into gene expression profiles induced by Socs3 depletion in keratinocytes.Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis.Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.Elevated levels of serum MRP8/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease.Exploring the Psoriatic Arthritis Proteome in Search of Novel Biomarkers.Elevated calprotectin in patients with atrial fibrillation with and without heart failure.Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity.The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin Disease.S100A8/A9 in Inflammation.
P2860

S-calprotectin (S100A8/S100A9): a potential marker of inflammation in patients with psoriatic arthritis.

Item
http://www.wikidata.org/entity/Q33739148
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
S-calprotectin (S100A8/S100A9) ...... ents with psoriatic arthritis.
@ast
S-calprotectin (S100A8/S100A9) ...... ents with psoriatic arthritis.
@en
type
label
S-calprotectin (S100A8/S100A9) ...... ents with psoriatic arthritis.
@ast
S-calprotectin (S100A8/S100A9) ...... ents with psoriatic arthritis.
@en
prefLabel
S-calprotectin (S100A8/S100A9) ...... ents with psoriatic arthritis.
@ast
S-calprotectin (S100A8/S100A9) ...... ents with psoriatic arthritis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
S-calprotectin (S100A8/S100A9) ...... ients with psoriatic arthritis
@en
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P921
P932